Multi-Omics for Maternal Health After Preeclampsia

Part of paid clinical trials in San Diego, California.

Sponsor
University of California, San Diego
Study ID
NCT06340152
Status
Recruiting
Apply to this trial

Conditions

  • Pre-Eclampsia
  • Pregnancy Induced Hypertension

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 50 Years
Healthy Volunteers
Accepted

Study Details

To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.

Key Dates

Start date
Dec 20, 2023
Status verified
Apr 2025
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
1,100 participants (estimated)

Arms

  • Arm: Low-risk pregnancy
    Pregnant subjects with none of the following: chronic hypertension, pregestational diabetes, renal disease, autoimmune disease, history of preterm preeclampsia in a prior pregnancy
  • Arm: High-risk pregnancy
    Pregnant subjects with one or more of the following: chronic hypertension, pregestational diabetes, renal disease, autoimmune disease, history of preterm preeclampsia in a prior pregnancy

Primary Outcome Measure

Preeclampsia [ Time Frame: 2nd trimester - 13 months postpartum ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San DiegoSan DiegoCalifornia92037
Maya Selvaraj
[email protected]
858-776-8374
Louise Laurent, MD, PhD (PRINCIPAL_INVESTIGATOR)
Marni Jacobs, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Diego, CA

By research site
University of California, San Diego· San Diego, CA

Related Studies